section name header

Basics

Basics

Overview

Paraneoplastic syndromes (PNS) are a diverse group of systemic disorders resulting from the metabolic effects of cancer in tissues remote from the tumor. These disorders are usually caused by production and release of substances not normally released by the tumor cell of origin or in amounts not normally produced by those cells. Other etiologies of PNS aside from production of metabolically active substances include autoimmune disease stimulation, immune complex formation, immunosuppression, and ectopic receptor production/competitive blockade of normal hormones. PNS may also occur secondary to substances produced by normal cells due to the presence of the tumor (e.g., tumor necrosis factor production by reticuloendothelial cells contributing to cancer cachexia). Many PNS in veterinary medicine have an unknown etiology. Pathophysiology depends on the specific PNS (see Table 1).

Signalment

Any dog or cat with a histologically malignant (most common) or benign cancer (rare)

Signs

Vary with tumor type and organ systems affected but include:

  • Alopecia (feline paraneoplastic syndrome)
  • Anemia
  • Cachexia
  • Cutaneous flushing
  • Diencephalic syndrome
  • Disseminated intravascular coagulation
  • Eosinophilia
  • Gastroduodenal ulceration
  • Hypercalcemia
  • Hypertrophic osteopathy
  • Hypoglycemia
  • Myelofibrosis
  • Neutrophilic leukocytosis
  • Nodular dermatofibrosis
  • Polycythemia
  • Superficial necrolytic dermatitis
  • Thrombocytopathy
  • Thrombocytopenia
  • Thrombocytosis

Causes & Risk Factors

Production and release of substances not normally released by the tumor cell of origin or in amounts not normally produced by those cells and the substances' subsequent effects on target tissues.

Diagnosis

Diagnosis

Differential Diagnosis

Varies with syndrome

CBC/Biochemistry/Urinalysis

Helpful in identifying and monitoring several of the reported syndromes.

Other Laboratory Tests

Ionized calcium and parathormone levels-assess patients with hypercalcemia; hypercalcemia of malignancy usually characterized by high ionized calcium and low PTH, may occasionally have elevated PTH-rP.

Imaging

  • Radiography-detect hypertrophic osteopathy
  • Advanced imaging (CT or MRI)-detect occult tumor

Diagnostic Procedures

Biopsy-diagnose paraneoplastic skin lesions

Treatment

Treatment

Medications

Medications

Drug(s)

Depends on underlying tumor type

Follow-Up

Follow-Up

Patient Monitoring

As for underlying tumor type

Miscellaneous

Miscellaneous

Abbreviations

  • CT = computed tomography
  • MRI = magnetic resonance imaging
  • PTH = parathormone

Author Laura D. Garrett

Consulting Editors Timothy M. Fan

Acknowledgment The author and editors acknowledge the prior contribution of Wallace B. Morrison.

Suggested Reading

Lucas P, Lacoste H, de Lorimier LP, Fan TM. Treating paraneoplastic hypercalcemia in dogs and cats. Vet Med May 1, 2007.

Robat CS, Cesario L, Gaeta R, Miller M, Schrempp D, Chun R. Clinical features, treatment options, and outcome in dogs with thymoma: 116 cases (1999-2010). J Am Vet Med Assoc 2013, 243:14481454.

Sternberg RA, Wypij J, Barger AM. An overview of multiple myeloma in dogs and cats. Vet Med Oct 1, 2009.

Turek MM. Cutaneous paraneoplastic syndromes in dogs and cats: A review of the literature. Vet Dermatol 2003, 14:279296.

Withers SS, Johnson EG, Culp WT, Rodriguez COJr, Skorupski KA, Rebhun RB. Paraneoplastic hypertrophic osteopathy in 30 dogs. Vet Comp Oncol 2013 Mar 14. [Epub ahead of print]